Velta
Vertically integrated titanium producer supplying powder feedstock for additive manufacturing and producing finished medical implants via 3D printing; unique zero-waste Velta Ti Process reduces titanium production costs 4x vs conventional Kroll method.
- CEO / Founder
- Andriy Brodskyy
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $5M
- Key Investors
- Traxys Group; European Lithium; Export-Import Bank of the United States (LOI)
Technology & Products
Key Products
Titanium powder for additive manufacturing; Titanium feedstock (ilmenite concentrate); Custom 3D-printed titanium medical implants for amputees; Titanium metal and alloys via Velta Ti Process; Ilmenite, zirconium, and clay production; Critical raw materials cluster development
Technological Advantage
Proprietary Velta Ti Process (patented 2020 for titanium metal, 2021 for alloys) reduces production costs 4x vs Kroll method industry standard; zero-waste process with environmental compliance; ability to scale from R&D powder (semi-industrial Dnipro facility) to full-scale production; seamless integration of feedstock supply with AM application minimizes supply chain friction.
Differentiation
Value Proposition
Supplies 2% of global titanium feedstock market at 4x lower cost than conventional methods via proprietary zero-waste Velta Ti Process; vertically integrated from mine to finished AM products eliminates supply chain intermediaries; capability to produce custom 3D-printed titanium medical implants on-demand.
How They Differentiate
Vertical integration from mining to finished products; proprietary Velta Ti process with lower energy consumption than conventional Kroll method; zero-waste production; established R&D center in Dnipro (opened 2017); medical implant production for war amputees; developing Ukraine's first critical raw materials cluster; collaboration with U.S. International Development Finance Corporation; resilience demonstrated through wartime operations.
Market & Competition
Target Customers
AM companies, aerospace manufacturers, medical device makers, industrial companies requiring titanium feedstock or finished implants
Industry Verticals
Additive Manufacturing; Aerospace & Defense; Medical Devices; Industrial Manufacturing
Growth & Milestones
Growth Metrics
Holds 2% of global titanium feedstock market; commercial shipments began 2012; scaled from semi-industrial to supporting AM applications division; established Velta Medical division in 2023 for medical implant production.
Major Milestones
2006: Velta founded; 2011: Mining and processing complex completed in Kirovograd region (8-month construction, $90M investment); 2012: Commercial titanium feedstock shipments began; 2020: Velta Ti Process patented (titanium metal production); 2021: Velta Ti Process extension patented (titanium alloys); 2023: Velta Medical launched (3D-printed titanium medical implants); 2024: Third US patent received during wartime operations
Notable Customers
Chemours (DuPont), Precheza, Traxys